Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia

Clinical Infectious Diseases

Volumn 54, Issue 1, 2012, Pages 111-118

  Jarrin, Inma ^a   Pantazis, Nikos ^b   Gill, M John ^c   Geskus, Ronald ^d,e   Perez Hoyos, Santiago ^f   Meyer, Laurence ^g   Prins, Maria ^e   Touloumi, Giota ^b   Johnson, Anne ^h   Hamouda, Osamah ⁱ   De Olalla, Patricia García ^j   Porter, Kholoud ^k   Del Amo, Julia ^a  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF CALGARY   (Canada)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e Amsterdam Health Service ^*  (Netherlands)

^f CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^g BICÊTRE HOSPITAL   (France)

^h ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

ⁱ ROBERT KOCH INSTITUTE   (Germany)

^j IDIAP Jordi Gol i Gurina   (Spain)

^k MEDICAL RESEARCH COUNCIL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; AUSTRALIA; CANADA; DISEASE COURSE; DRUG UPTAKE; EUROPE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GEOGRAPHY; HIV INFECTIONS; HUMANS; MALE; TIME FACTORS;

EID: 84555209248     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir814     Document Type: Article

References (27)

1. Del Amo J, Likatavicius G, Pérez-Cachafeiro S, et al. The epidemiology of HIV and AIDS reports in migrants in the 27 European Union countries, Norway and Iceland: 1999-2006. Eur J Public Health 2011; 21:620-6.
2. Krentz H, Gill J. The five-year impact of an evolving global epidemic, changing migration patterns, and policy changes in a regional Canadian HIV population. Health Policy 2009; 90:296-302.
3. Burns FM, Fakoya AO, Copas AJ, French PD. Africans in London continue to present with advanced HIV disease in the era of highly active antiretroviral therapy. AIDS 2001; 15:2453-5. (Pubitemid 34014616)
4. Caro-Murillo AM, Gutierrez F, Manuel Ramos J, et al. HIV infection in immigrants in Spain: epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006). Enferm Infecc Microbiol Clin 2009; 27:380-8.
5. Del Amo J, Petruckevitch A, Phillips AN, et al. Disease progression and survival in HIV-1-infected Africans in London. AIDS 1998; 12:1203-9. (Pubitemid 28302423)
6. Staehelin C, Rickenbach M, Low N, et al. Migrants from sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival. AIDS 2003; 17:2237-44. (Pubitemid 37338897)
7. Müller V, von Wyl V, Yerly S, et al. African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study. AIDS 2009; 23:1269-76.
8. Meyer L, Chaix ML, Nagy Z, et al. Low CD4 T cell counts in sub-Saharan African subjects enrolled at the time of HIV-1 primary infection in the French ANRS PRIMO cohort. Presented at: Proceedings of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 22-25 July 2007. Sydney, Australia, 2007. TUPEB004.
9. PICUM. Platform for international cooperation on undocumented migrants. Available at: http://www.picum.org. Accesssed 1 October 2010.
10. CASCADE (Concerted Action on Seroconversion to AIDS and Death in Europe) Collaboration. Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE. HIV Med 2000; 1:224-31.
11. Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics 1978; 34:541-54. (Pubitemid 9067879)
12. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med 2007; 26:2389-430. (Pubitemid 46730255)
13. Geskus RB. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring. Biometrics 2011; 67:39-49.
14. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94:496-509.
15. Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol 2009; 170:244-56.
16. Phillips AN, Lee CA, Elford J, Janossy G, Kernoff PB. The cumulative risk of AIDS as the CD4 lymphocyte count declines. J Acquir Immune Defic Syndr 1992; 5:148-52.
17. Llácer A, Zunzunegui MV, del Amo J, Mazarrasa L, Bolumar F. The contribution of a gender perspective to the understanding of migrants' health. J Epidemiol Commun H 2007; 61(Suppl 2):ii4-10. (Pubitemid 350207346)
18. Frater AJ, Dunn DT, Beardall AJ, et al. Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy. AIDS 2002; 16:1139-46. (Pubitemid 34533852)
19. Elford J, Ibrahim F, Bukutu C, Anderson J. Uptake of antiretroviral treatment among people living with HIV in London: ethnicity, gender and sexual orientation. Sex Transm Infect 2008; 84:176-8. (Pubitemid 351871487)
20. Breton G, Lewden C, Spire B, et al. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France. HIV Med 2007; 8:164-70. (Pubitemid 46915687)
21. Jensen-Fangel S, Pedersen L, Pedersen C, et al. The effect of race/ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type 1-infected patients. Clin Infect Dis 2002; 35:1541-8. (Pubitemid 36024181)
22. Nellen JF, Wit FW, De Wolf F, Jurriaans S, Lange JM, Prins JM. Virologic and immunologic response to highly active antiretroviral in indigenous and nonindigenous HIV-1-infected patients in the Netherlands. J Acquir Immune Defic Syndr 2004; 36:943-50. (Pubitemid 38944090)
23. Staehelin C, Egloff N, Rickenbach M, Kopp C, Furrer H. Swiss HIV Cohort Study. Migrants from sub-Saharan Africa in the Swiss HIV Cohort Study: a single center study of epidemiologic migrationspecific and clinical features. AIDS Patient Care STDS 2004; 18: 665-75. (Pubitemid 39579160)
24. Bhopal R. Revisiting race/ethnicity as a variable in health research. Am J Public Health 2002; 92:156-7. (Pubitemid 34101417)
25. Bhopal R. Glossary of terms relating to ethnicity and race: for reflection and debate. J Epidemiol Commun H 2004; 58:441-5.
26. Del Amo J, Broring G, Hamers F, Infuso A, Fenton K. Monitoring HIV/AIDS in migrants communities in Europe. AIDS 2004; 18:1867-73. (Pubitemid 39313202)
27. European Centre for Disease Prevention and Control. HIV testing: increasing uptake and effectiveness in the European Union. Stockholm: ECDC, 2010.